Ondansetron Injection | Suppliers | Impurities | Impurity Standards| PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Ondansetron Injection
Others

PharmaCompass Sponsored Ads

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Aspen API. More than just an API™

Contact Supplier

jdmfs-not-supported-m-2025-04-28

Ondansetron Injection

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

29 API Suppliers, 8 USDMF, 9 EU WC, 3 KDMF, 10 NDC API, 20 Listed Suppliers, $ API Reference Price

29 API Suppliers
8 USDMF
9 EU WC
3 KDMF
10 NDC API
20 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

41 Drugs in Development

41 Drugs in Development

INTERMEDIATES

13 Intermediate Suppliers

13 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

456 FDF Dossiers, 29 FDA Orange Book, 143 Europe, 24 Canada, 103 Australia, 49 South Africa, 108 Listed Dossiers

456 FDF Dossiers
29 FDA Orange Book
143 Europe
24 Canada
103 Australia
49 South Africa
108 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, ORALLY DISINTEGRATING;ORAL - 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FILM;ORAL - 4MG, FILM;ORAL - 8MG

TABLET, ORALLY DISINTEGRATING;ORAL - 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, ORALLY DISINTEGRATING;ORAL - 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FILM;ORAL - 4MG
FILM;ORAL - 8MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 6 Rochem International Inc, 23 SPI Pharma, 12 DKSH, 2 Pharm-RX Chemical, 6 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 9 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 17 BASF, 1 Bioplus Life Sciences, 11 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 1 Finar, 11 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 37 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 29 Roquette, 13 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 5 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 5 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

86 Fillers, Diluents & Binders, 46 Disintegrants & Superdisintegrants, 46 Coating Systems & Additives, 40 Direct Compression, 32 Thickeners and Stabilizers, 27 Taste Masking, 26 Controlled & Modified Release, 25 Granulation, 23 Chewable & Orodispersible Aids, 21 Lubricants & Glidants, 20 Solubilizers, 18 Film Formers & Plasticizers, 16 Co-Processed Excipients, 14 Parenteral, 12 Topical, 9 Empty Capsules, 8 Rheology Modifiers, 7 API Stability Enhancers, 7 Emulsifying Agents, 4 Vegetarian Capsules, 4 Coloring Agents, 2 Surfactant & Foaming Agents, 1 Soft Gelatin

86 Fillers, Diluents & Binders
46 Disintegrants & Superdisintegrants
46 Coating Systems & Additives
40 Direct Compression
32 Thickeners and Stabilizers
27 Taste Masking
26 Controlled & Modified Release
25 Granulation
23 Chewable & Orodispersible Aids
21 Lubricants & Glidants
20 Solubilizers
18 Film Formers & Plasticizers
16 Co-Processed Excipients
14 Parenteral
12 Topical
9 Empty Capsules
8 Rheology Modifiers
7 API Stability Enhancers
7 Emulsifying Agents
4 Vegetarian Capsules
4 Coloring Agents
2 Surfactant & Foaming Agents
1 Soft Gelatin

DIGITAL CONTENT

30 News #PharmaBuzz

30 News #PharmaBuzz

GLOBAL SALES INFORMATION

130 Regulatory FDF Prices

130 Regulatory FDF Prices

MARKET PLACE

14 APIs, 23 FDF Dossiers

14 APIs
23 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents, 2 Health Canada Patents

4 US Patents
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 Others

4 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 1,390 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

4 All

01 4 Aozeal Certified Standards

filter CAS Number Reset all filters

4 All

01 11076198-52-1

02 1119812-29-2

03 127387-31-1

04 199614-64-9

filter Details Reset all filters

4 All

01 4In stock

filter Country Reset all filters

4 All

01 4U.S.A

Athena Ondansetron

Product Main Page

01

Aozeal Certified Standards

BioProcess International Europe

Not Confirmed

Aozeal Certified Standards

BioProcess International Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Ondansetron EP Impurity B

CAS Number : 1076198-52-1

Quantity Per Vial :

Sale Unit :

Price :

Details : In stock

Monograph :

Storage :

Code/Batch No : O0005.03

Product Web Link

Digital Content

02

Aozeal Certified Standards

BioProcess International Europe

Not Confirmed

Aozeal Certified Standards

BioProcess International Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Ondansetron Related Compound A

CAS Number : 119812-29-2

Quantity Per Vial :

Sale Unit :

Price :

Details : In stock

Monograph :

Storage :

Code/Batch No : O0005.02

Product Web Link

Digital Content

03

Aozeal Certified Standards

BioProcess International Europe

Not Confirmed

Aozeal Certified Standards

BioProcess International Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Ondansetron Related Compound C

CAS Number : 27387-31-1

Quantity Per Vial :

Sale Unit :

Price :

Details : In stock

Monograph :

Storage :

Code/Batch No : O0005.04

Product Web Link

Digital Content

04

Aozeal Certified Standards

BioProcess International Europe

Not Confirmed

Aozeal Certified Standards

BioProcess International Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Ondansetron Related Compound D

CAS Number : 99614-64-9

Quantity Per Vial :

Sale Unit :

Price :

Details : In stock

Monograph :

Storage :

Code/Batch No : O0005.05

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!